Corton Capital Inc. Acquires New Holdings in LifeMD, Inc. $LFMD

Corton Capital Inc. acquired a new position in LifeMD, Inc. (NASDAQ:LFMD) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 10,412 shares of the company’s stock, valued at approximately $142,000.

Other hedge funds also recently bought and sold shares of the company. CWM LLC increased its holdings in shares of LifeMD by 17.5% in the 1st quarter. CWM LLC now owns 9,050 shares of the company’s stock valued at $49,000 after acquiring an additional 1,351 shares during the period. Royce & Associates LP boosted its position in LifeMD by 3.5% during the first quarter. Royce & Associates LP now owns 1,155,231 shares of the company’s stock valued at $6,284,000 after purchasing an additional 39,240 shares in the last quarter. GSA Capital Partners LLP boosted its position in LifeMD by 39.9% during the first quarter. GSA Capital Partners LLP now owns 103,803 shares of the company’s stock valued at $565,000 after purchasing an additional 29,582 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its stake in LifeMD by 5.4% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 981,894 shares of the company’s stock valued at $5,342,000 after purchasing an additional 50,600 shares during the last quarter. Finally, Virtu Financial LLC bought a new position in LifeMD in the first quarter worth about $143,000. Hedge funds and other institutional investors own 35.52% of the company’s stock.

Insider Activity

In other news, insider Nicholas P. Alvarez sold 75,000 shares of the firm’s stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $5.92, for a total value of $444,000.00. Following the completion of the transaction, the insider directly owned 605,000 shares in the company, valued at $3,581,600. This trade represents a 11.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 18.40% of the stock is currently owned by insiders.

LifeMD Price Performance

Shares of LFMD opened at $5.42 on Wednesday. The firm has a market capitalization of $257.02 million, a PE ratio of -25.81 and a beta of 1.57. The company has a debt-to-equity ratio of 9.21, a current ratio of 0.77 and a quick ratio of 0.72. The company’s fifty day moving average price is $6.26 and its 200-day moving average price is $8.80. LifeMD, Inc. has a 1-year low of $4.13 and a 1-year high of $15.84.

Analyst Ratings Changes

Several analysts have commented on LFMD shares. HC Wainwright decreased their price target on shares of LifeMD from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Wall Street Zen lowered shares of LifeMD from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Zacks Research upgraded shares of LifeMD from a “strong sell” rating to a “hold” rating in a research note on Friday, September 5th. Lake Street Capital cut their price target on shares of LifeMD from $18.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, August 6th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of LifeMD in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $13.17.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.